FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

AM Garcia-Turner

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Living Beings

Nude Mouse

Co-author Network

Publications

TOP 3
Ilkcan Cokgor; Gamal Akabani; Chien-Tsun Kuan; Henry S Friedman; Allan H Friedman; R Edward Coleman; Roger E McLendon; Sandra H Bigner; Xiao-Guang Zhao; AM Garcia-Turner; Charles N Pegram; Carol J Wikstrand; Timothy D Shafman; James E Herndon; James M Provenzale; Michael R Zalutsky; Darell D Bigner
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas.
Henry S Friedman; James Pluda; Jennifer A Quinn; Reginald Ewesuedo; L Long; Allan H Friedman; Ilkcan Cokgor; O Michael Colvin; Michael M Haglund; DM Ashley; Jeremy Rich; J Sampson; Anthony E Pegg; Robert C Moschel; Roger E McLendon; James M Provenzale; ES Stewart; Sandra Tourt-Uhlig; AM Garcia-Turner; James E Herndon; Darell D Bigner; M Eileen Dolan
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
Gamal Akabani; Ilkcan Cokgor; R Edward Coleman; D González Trotter; Terence Z Wong; Henry S Friedman; Allan H Friedman; AM Garcia-Turner; James E Herndon; David DeLong; Roger E McLendon; Xiao-Guang Zhao; Charles N Pegram; James M Provenzale; Darell D Bigner; Michael R Zalutsky
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of AM Garcia-Turner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: Ilkcan Cokgor; Gamal Akabani; Chien-Tsun Kuan; Henry S Friedman; Allan H Friedman; R Edward Coleman; Roger E McLendon; Sandra H Bigner; Xiao-Guang Zhao; AM Garcia-Turner; Charles N Pegram; Carol J Wikstrand; Timothy D Shafman; James E Herndon; James M Provenzale; Michael R Zalutsky; Darell D Bigner
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3862-72.
2000: Henry S Friedman; James Pluda; Jennifer A Quinn; Reginald Ewesuedo; L Long; Allan H Friedman; Ilkcan Cokgor; O Michael Colvin; Michael M Haglund; DM Ashley; Jeremy Rich; J Sampson; Anthony E Pegg; Robert C Moschel; Roger E McLendon; James M Provenzale; ES Stewart; Sandra Tourt-Uhlig; AM Garcia-Turner; James E Herndon; Darell D Bigner; M Eileen Dolan
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(20):3522-8.
2000: Gamal Akabani; Ilkcan Cokgor; R Edward Coleman; D González Trotter; Terence Z Wong; Henry S Friedman; Allan H Friedman; AM Garcia-Turner; James E Herndon; David DeLong; Roger E McLendon; Xiao-Guang Zhao; Charles N Pegram; James M Provenzale; Darell D Bigner; Michael R Zalutsky
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy.
International journal of radiation oncology, biology, physics 2000;46(4):947-58.